Prices delayed by at least 15 minutes | Print
Argent Biopharma Limited (RGT)
ORD NPV (DI)Open
21.5p
Previous close
21.5p
Trade high
23p
Volume
6,329
Year high
24.00p
Year low
20.00p
Dividend yield
-
Market capitalisation
£9.74 mn
P/E ratio
-
ISIN
AU0000326647
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Argent Biopharma Ltd is an innovative drug discovery company that addresses unmet medical needs by combining PolyPharmacology and Nanotechnology, aspiring to be a renowned global leader in the biopharmaceutical sector. Its products includes CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury and ARDS and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 03/05/2024 | 03:32:14 | 23 | 10 | 2.30 |
| 03/05/2024 | 03:32:14 | 23 | 10 | 2.30 |
| 03/05/2024 | 03:24:20 | 20 | 10 | 2.00 |
| 03/05/2024 | 03:23:49 | 20 | 1 | 0.20 |
| 03/05/2024 | 02:47:03 | 22.52 | 22 | 4.95 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.